Clal Biotechnology Industries Ltd. (TLV: CBI)

CBI Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.74	5.73	7.44	53.05	68.16	37.55
Short-Term Investments	-	-	-	-	13.53	76.98
Trading Asset Securities	2.8	7.63	5.44	-	104.81	-
Cash & Short-Term Investments	9.54	13.36	12.89	53.05	186.5	114.53
Cash Growth	-9.33%	3.66%	-75.71%	-71.55%	62.84%	10.37%
Accounts Receivable	-	-	-	5.53	8.89	14.19
Other Receivables	0.73	0.02	0.65	1.9	1.06	0.1
Receivables	0.73	0.02	0.65	7.44	9.95	14.29
Inventory	-	-	-	3.73	4.44	5.58
Prepaid Expenses	-	0.82	2.59	2.68	2.58	1.5
Other Current Assets	-	0.49	0.52	10.71	7.63	1.46
Total Current Assets	10.27	14.69	16.64	77.61	211.09	137.36
Property, Plant & Equipment	1.42	4.73	5.09	18.06	14.94	16.32
Long-Term Investments	95.43	138.22	155.69	127.83	138.71	147.64
Other Intangible Assets	-	-	-	215.78	241.05	304.69
Other Long-Term Assets	0.21	0.75	5.28	5.63	8.23	10.96
Total Assets	107.32	158.39	182.69	444.92	614.03	616.97
Accounts Payable	-	-	-	14.6	9.62	14.1
Accrued Expenses	-	1.16	1.01	8.29	7.85	11.1
Current Portion of Long-Term Debt	3.46	4.97	-	6.24	5.11	10.94
Current Portion of Leases	-	0.47	1.85	2.43	2.02	1.95
Current Unearned Revenue	-	-	-	2.37	2.33	1.29
Other Current Liabilities	1.25	0.07	0.05	1.72	1.36	1.66
Total Current Liabilities	4.7	6.66	2.91	35.65	28.28	41.05
Long-Term Debt	18.27	25.97	27.39	35.86	37.98	42.76
Long-Term Leases	1.41	4.35	7.49	9.25	5.72	7.01
Long-Term Unearned Revenue	-	-	-	24.52	23.36	27.46
Other Long-Term Liabilities	-	-	-	1.26	4.91	0.84
Total Liabilities	24.38	36.98	37.79	106.55	100.24	119.12
Common Stock	1.61	1.61	1.61	1.61	1.61	1.61
Additional Paid-In Capital	1,297	1,296	1,296	1,295	1,295	1,292
Retained Earnings	-1,373	-1,332	-1,301	-1,239	-1,113	-1,222
Treasury Stock	-10	-10	-10	-10	-0.26	-
Comprehensive Income & Other	144.93	143.76	139.37	125.29	123.72	152.05
Total Common Equity	60.12	99.36	126.03	172.59	306.35	223.6
Minority Interest	22.82	22.05	18.87	165.78	207.45	274.25
Shareholders' Equity	82.94	121.41	144.9	338.37	513.79	497.85
Total Liabilities & Equity	107.32	158.39	182.69	444.92	614.03	616.97
Total Debt	23.13	35.76	36.73	53.78	50.82	62.67
Net Cash (Debt)	-13.59	-22.4	-23.85	-0.73	135.68	51.87
Net Cash Growth	-	-	-	-	161.59%	0.38%
Net Cash Per Share	-0.08	-0.14	-0.15	-0.00	0.84	0.32
Filing Date Shares Outstanding	158.7	156.85	156.85	156.85	161.1	161.24
Total Common Shares Outstanding	158.7	156.85	156.85	156.85	161.1	161.24
Working Capital	5.56	8.03	13.73	41.96	182.82	96.3
Book Value Per Share	0.38	0.63	0.80	1.10	1.90	1.39
Tangible Book Value	60.12	99.36	126.03	-43.19	65.3	-81.1
Tangible Book Value Per Share	0.38	0.63	0.80	-0.28	0.41	-0.50

Source: S&P Capital IQ. Standard template. Financial Sources.